MBIO
Mustang Bio Inc
$0.48
0.03 (5.40%) Today
— up— down
Market Cap
$4M-69.5%
Revenue (TTM)
$0
$0Net Income (TTM)
$-3,480,736
$-3,480,736EPS (TTM)
-0.46
-0.46Shares Out
7.58M
7.58MOpen
$0.48
$0.48Previous Close
$0.51
$0.51Day Range
$0.47 – $0.51
$0.47 – $0.5152-Week Range
$0.47 – $1.85
$0.47 – $1.85Beta
2.18
2.18Volume
48.99K
48.99KAvg Volume
96.28K
96.28KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout MBIO
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency (X-SCID).
Related
News
N/AN/AN/AN/AN/A
Iran appeals to US voters as American troops leave Iraq - Reuters
Reuters · 2h ago
Oil climbs after Trump denies he is willing to ease sanctions on Iran - Reuters
Reuters · 3h ago
US forces exit Iraq, emboldening Iran's proxies and Islamic State - Reuters
Reuters · 3h ago
US Senate blocks measure demanding report on rights violations in West Bank - Reuters
Reuters · 4h ago
Trump says he does not know if Iran is going to 'give up yet' - Reuters
Reuters · 7h ago